NIOX Group Plc (AIM:NIOX)

Market Cap	284.51M -7.7%
Revenue (ttm)	48.70M +24.9%
Net Income	7.00M -40.2%
EPS	0.02 -36.7%
Shares Out	420.87M
PE Ratio	41.22
Forward PE	20.41
Dividend	0.02 (2.29%)
Ex-Dividend Date	May 21, 2026

Volume	851,611
Open	68.60
Previous Close	67.60
Day's Range	66.80 - 68.60
52-Week Range	53.84 - 76.00
Beta	-0.08
Analysts	Strong Buy
Price Target	81.50 (+20.56%)
Earnings Date	Sep 24, 2026

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Pl...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 97
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: NIOX

Financial Performance

In 2025, NIOX Group's revenue was 48.70 million, an increase of 16.51% compared to the previous year's 41.80 million. Earnings were 7.00 million, an increase of 89.19%.

Analyst Summary

According to 6 analysts, the average rating for NIOX stock is "Strong Buy." The 12-month stock price target is 82p, which is an increase of 20.56% from the latest price.

Price Target

82p

(20.56% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error